(Q40637515)

22 September 2017

title

Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma (English)

1 reference

22 September 2017

Rose DM

1

1 reference

22 September 2017

Chapman WC

2

1 reference

22 September 2017

Brockenbrough AT

3

1 reference

22 September 2017

Wright JK

4

1 reference

22 September 2017

Rose AT

5

1 reference

22 September 2017

Meranze S

6

1 reference

22 September 2017

Mazer M

7

1 reference

22 September 2017

Blair T

8

1 reference

22 September 2017

Blanke CD

9

1 reference

22 September 2017

Debelak JP

10

1 reference

22 September 2017

Pinson CW

11

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

The American Journal of Surgery

22 September 2017

published in

1 reference

22 September 2017

volume

177

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

405-410

1 reference

Liver, gallbladder, extrahepatic bile ducts, and pancreas

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Nonresectional therapies for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Current treatment modalities for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Treatment of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Treatment of hepatocellular carcinoma in patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Treatment of hepatocellular carcinoma: too many options?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Liver-spleen infarcts following transcatheter chemoembolization: a case report and review of the literature on adverse effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Primary treatment of hepatocellular carcinoma by arterial chemoembolization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Prognosis of primary hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Chemoembolization for hepatocellular carcinoma. What, when, and for whom?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900069-0

10.1016/S0002-9610(99)00069-0

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference